Juniper Pharma Services continues its strategic capital investment in oral solid dose services

4 months ago

Nottingham, UK – Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, is continuing its strategic investment in oral solid dose manufacturing with a $1.7m purchase of three additional pieces of processing equipment. This investment enhances JPS’ commitment to rapidly transform promising molecules into successful

Juniper Pharma Services expands laboratory facilities to meet with growing demand

4 months ago

Nottingham, UK – Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, has announced a significant expansion to its UK-based drug development and clinical trial manufacturing facilities. The extension provides four additional process development laboratories at its Nottingham site, improving the output and efficiency of

Juniper Pharma Services to Participate in Inaugural West Coast Advancing Drug Development Forum

4 months ago

Nottingham, UK – Juniper Pharma Services (JPS), a Contract Development and Manufacturing organisation (CDMO) specialising in the development of challenging small molecules, will be attending the 2nd ‘Advancing Drug Development Forum (ADDF) – Making the Impossible, Possible.’ on June 14th at the San Francisco Wine School, California. JPS will be joining key opinion leaders at